Allergies News and Research

Latest Allergies News and Research

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Wake Forest University School of Medicine honours researchers

Wake Forest University School of Medicine honored eight of its researchers with awards for excellence at the 13th Annual Research Awards Day Oct. 1.

12 Oct 2009

Public forum and scientific workshop on women's health issues

The Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital will host a public forum and scientific workshop Oct. 14 to 16 to discuss emerging issues of importance for the National Institutes of Health (NIH) for women's health research in the coming decade.

12 Oct 2009

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.

12 Oct 2009

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.

12 Oct 2009

Aspen Institute and TIME magazine to present panel discussions on health care reform

With health care reform headed to the floor of the House and Senate, the Aspen Institute and TIME magazine will present a day of panel discussions designed to shed light on what the looming changes will mean for the American people.

9 Oct 2009

NIAID awards $60M for research contracts to discover new adjuvants

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.

9 Oct 2009

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Valensa International (Orlando, FL USA) announced today that it has initiated a broad out licensing effort for University of Illinois patent (US 5,527,533 and its foreign equivalents) for the use of the astaxanthin in eye healthcare dietary supplement applications.

8 Oct 2009

Phadia launches new, advanced assays for accurate diagnosis of celiac disease

Phadia Inc., worldwide leaders in the development, manufacturing and marketing of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases, today announced the launch of a two new, highly -reliable assays to support the accurate diagnosis of celiac disease.

8 Oct 2009

Study links improving air quality and fewer cases of cases of ear infections in children

Strides in improving the nation's air quality over the past ten years may be a factor in fewer cases of ear infections (otitis media) in children. These results are according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

8 Oct 2009

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.

7 Oct 2009

Research to explore diagnosis and treatment of rare diseases

The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.

7 Oct 2009

Vaccination can lower the risks of allergy in children

Vaccination can lower children's risk of allergy. Cathleen Muche-Borowski and her coauthors present a clinical practice guideline for allergy prevention in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2009; 106[39]: 625-31).

7 Oct 2009

Health educator stresses the importance of sinus cleansing

With fall allergy season underway and Americans concerned about keeping their family safe from H1N1 and other flu viruses, health educator and fitness trainer Isabella "Betti" Jones is urging Americans to take a proactive, natural approach to staying healthy - the important step of daily sinus cleansing.

6 Oct 2009

NIAID's grant to VBI for biomedical research on infectious diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year, $27,670,448 contract to the CyberInfrastructure Group (CIG) of the Virginia Bioinformatics Institute (VBI) at Virginia Tech to support the biomedical research community's work on infectious diseases.

6 Oct 2009

Children rally for improved education and funding for food allergies

More than eighty children with personal stories of the challenges of managing food allergies spoke to their elected representatives and rallied for improved education and funding for food allergies during the third Food Allergy & Anaphylaxis Network’s (FAAN) Kids’ Congress on Capitol Hill last week.

6 Oct 2009

Sequella receives ARRA funds to manufacture SQ109 for treating tuberculosis

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $694,000 grant supplement as part of the American Recovery and Reinvestment Act (ARRA) of 2009.

6 Oct 2009

Features of Ingenix's CareTracker EMR e-prescribing solution expanded

Ingenix today announced that it has expanded the electronic prescribing (e-prescribing) capabilities of its CareTracker™ EMR solution. The new e-prescribing features are Surescripts® certified and allow physicians to access their patients’ prescription histories and drug benefit information as part of an electronic health record.

6 Oct 2009

Prednisporin is a key asset in the proposed acquisition of Fovea by Sanofi-Aventis

CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.

5 Oct 2009

Top ten sleep and beauty tips

Bob Hickman, United Feather & Down's Senior Vice Present of Sales and Marketing, and Neil A. Petrocelli, Borghese, Inc.'s Vice President of Marketing, list their top sleep and beauty tips.

5 Oct 2009

Allergies News and Research

Latest Allergies News and Research

NIH funds the University of California's consortium for immune disorder research

Wake Forest University School of Medicine honours researchers

Public forum and scientific workshop on women's health issues

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

Aspen Institute and TIME magazine to present panel discussions on health care reform

NIAID awards $60M for research contracts to discover new adjuvants

Valensa initiates licensing patent for the use of the astaxanthin as a dietary supplement

Phadia launches new, advanced assays for accurate diagnosis of celiac disease

Study links improving air quality and fewer cases of cases of ear infections in children

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Research to explore diagnosis and treatment of rare diseases

Vaccination can lower the risks of allergy in children

Health educator stresses the importance of sinus cleansing

NIAID's grant to VBI for biomedical research on infectious diseases

Children rally for improved education and funding for food allergies

Sequella receives ARRA funds to manufacture SQ109 for treating tuberculosis

Features of Ingenix's CareTracker EMR e-prescribing solution expanded

Prednisporin is a key asset in the proposed acquisition of Fovea by Sanofi-Aventis

Top ten sleep and beauty tips

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Allergies News and Research

Latest Allergies News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in